Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Toxic Encephalopathy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06551051
What this trial is testing

ADC-induced Neurotoxicity Treated With Duloxetine

Who this might be right for
Solid Tumour
Fudan University 37
Large-scale testing (Phase 3)Study completedNCT00039780
What this trial is testing

Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly Paclitaxel

Who this might be right for
Breast NeoplasmsBreast DiseasesMetastases, Neoplasm
BioNumerik Pharmaceuticals, Inc. 764
Testing effectiveness (Phase 2)Ended earlyNCT01499940
What this trial is testing

Study to Assess Prevention of Oxaliplatin-induced Neurotoxicity Through Vitamin D Pathway

Who this might be right for
Neurotoxicity
Gerald Higa, PharmD. 9
Not applicableStudy completedNCT00986648
What this trial is testing

A Multi-Center Group to Study Acute Liver Failure in Children

Who this might be right for
Acute Liver FailureHepatic Encephalopathy
University of Pittsburgh 158
Post-approval studies (Phase 4)UnknownNCT00274885
What this trial is testing

Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer

Who this might be right for
Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 58
Not applicableActive Not RecruitingNCT06798142
What this trial is testing

Risk Stratification and Heterogeneity for Organ Damage in Acute Diquat Poisoning

Who this might be right for
Toxic EncephalopathyDiquat Poisoning
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 193
Testing effectiveness (Phase 2)Ended earlyNCT00069927
What this trial is testing

Adderall XR Compared With Concerta in Treating Young Cancer Patients With Memory, Attention, and Depression

Who this might be right for
DepressionNeurotoxicityUnspecified Childhood Solid Tumor, Protocol Specific
University of South Florida 12
Not applicableStudy completedNCT03354455
What this trial is testing

Investigating the Causal Role of preSMA in Levodopa-induced Dyskinesia in Parkinson's Disease

Who this might be right for
Dyskinesia, Drug-InducedParkinson Disease
Danish Research Centre for Magnetic Resonance 20
Not applicableUnknownNCT04335916
What this trial is testing

Survey on Pre-ECT Evaluation and ECT Application

Who this might be right for
DepressionCatatoniaSchizophrenia+3 more
Klinički Bolnički Centar Zagreb 30
Testing effectiveness (Phase 2)UnknownNCT00884767
What this trial is testing

Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin

Who this might be right for
Chemotherapeutic Agent ToxicityColorectal CancerNeurotoxicity
Institut Cancerologie de l'Ouest 206
Not applicableStudy completedNCT01081197
What this trial is testing

Somatic Disease Among Alcohol Abusers in an Out-day Patients' Clinic

Who this might be right for
HEART DISEASELiver FailureDEPRESSIVE DISORDER+1 more
Helse Nord-Trøndelag HF 150
Large-scale testing (Phase 3)Study completedNCT00471445
What this trial is testing

Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients

Who this might be right for
NeurotoxicityPainPeripheral Neuropathy+1 more
Gary Morrow 462
Not applicableEnded earlyNCT00176553
What this trial is testing

A Pilot Study of Dextromethorphan for the Prevention and Treatment of Methotrexate Neurotoxicity

Who this might be right for
Neurotoxicity Syndromes
University of Medicine and Dentistry of New Jersey 20
Not applicableStudy completedNCT01322672
What this trial is testing

Peri-Anesthetic Imaging of Cognitive Dysfunction

Who this might be right for
Postoperative Cognitive DysfunctionDeliriumDementia+1 more
Vanderbilt University 6
Not applicableUnknownNCT01372787
What this trial is testing

Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer

Who this might be right for
AnxietyFatigueNausea and Vomiting+20 more
Gynecologic Oncology Group 103
Not applicableStudy completedNCT00305799
What this trial is testing

Hearing Loss and Dizziness in Patients Receiving Oxaliplatin for Solid Tumors

Who this might be right for
NeurotoxicityUnspecified Adult Solid Tumor, Protocol Specific
Case Comprehensive Cancer Center 59
Large-scale testing (Phase 3)WithdrawnNCT01492920
What this trial is testing

Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy

Who this might be right for
FatigueMalignant Ovarian Mixed Epithelial TumorNeuropathy+10 more
Gynecologic Oncology Group
Large-scale testing (Phase 3)Active Not RecruitingNCT03089905
What this trial is testing

Compare the Long-term Outcomes After Two Different Anaesthetics

Who this might be right for
AnesthesiaNeurotoxicityChild Development
Murdoch Childrens Research Institute 450
Not applicableEnded earlyNCT01050075
What this trial is testing

Acupuncture in Treating Nerve Pain in Patients With Stage I, Stage II, or Stage III Breast Cancer Who Are Receiving Paclitaxel

Who this might be right for
Breast CancerStage I Breast CancerStage II Breast Cancer+3 more
City of Hope Medical Center 7
Large-scale testing (Phase 3)Study completedNCT00775645
What this trial is testing

S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, II, or IIIA Breast Cancer Undergoing Chemo

Who this might be right for
Breast CancerChemotherapeutic Agent ToxicityFatigue+2 more
SWOG Cancer Research Network 437
Next Page